Nicotine is a highly addictive psychoactive substance that rapidly enters the bloodstream through the lungs and reaches the brain within seconds of inhalation. It binds to nicotinic acetylcholine receptors in the brain, triggering the dopaminergic reward pathway, which produces sensations of pleasure and reinforcement. This neurochemical mechanism conditions repeated use, leading to dependency. Additives like menthol further enhance nicotine absorption and prolong its presence in the body, intensifying addiction and affecting the central nervous system.

From a public health perspective, tobacco use is one of the leading preventable causes of death in India, accounting for approximately 1.35 million deaths annually, according to the WHO. It contributes to cancers (particularly lung and oral cancer), cardiovascular diseases, chronic respiratory illnesses, and strokes. The burden is not merely medical but economic—loss of productivity, increased healthcare expenditure, and impoverishment of households due to chronic illness.

India’s position as the world’s second-largest producer and consumer of tobacco complicates regulation. While cigarettes are not banned due to economic considerations, periodic tax increases aim to deter consumption. However, affordability remains a challenge. Thus, nicotine addiction is not just a behavioural issue but a systemic public health crisis requiring fiscal, regulatory, and behavioural interventions.

Tobacco taxation operates on the principle of price elasticity of demand. Higher prices discourage initiation among youth and reduce consumption among existing users, particularly those from low-income groups. Evidence from India, including a 2017 peer-reviewed study, indicates that a 10% increase in cigarette VAT rates was associated with measurable reductions in smoking prevalence among men. This demonstrates that fiscal measures can directly influence behavioural outcomes.

However, India’s current tax structure falls short of the WHO-recommended benchmark of 75% of retail price. Currently, taxes account for about 53% of the retail price of cigarettes. Historically, tax increases have not consistently kept pace with inflation, making tobacco products relatively affordable over time. This undermines the deterrent effect of taxation.

Additionally, differential taxation—such as reducing GST on beedis to 18%—creates distortions. Beedis are predominantly consumed by lower-income groups, and lower taxation may exacerbate health inequities. While recent upward revisions in excise duties and cess on smokeless tobacco are positive, aligning taxation with global best practices remains essential for effective tobacco control.

Differential taxation across tobacco products can have unintended consequences for social equity and health outcomes. While higher taxes on cigarettes may reduce consumption among urban and middle-income populations, lower taxes on beedis and smokeless tobacco—products predominantly used by lower-income groups—may sustain or even increase usage in vulnerable sections.

Beedis are more prevalent than cigarettes in many rural and economically weaker communities. Reducing GST to 18% represents a missed opportunity to discourage consumption in these groups. Given that tobacco-related diseases disproportionately affect poorer households, lower taxation may perpetuate a cycle of ill-health and poverty.

On the other hand, policymakers argue that sudden steep taxation on beedis may affect small-scale producers and informal sector workers. Therefore, a balanced approach is required—gradual tax harmonisation, combined with livelihood transition support for workers in the beedi industry. Public health goals must be aligned with social justice considerations to ensure equitable outcomes.

The tobacco industry has historically engaged in lobbying, misinformation campaigns, and attempts to influence policymaking to dilute tobacco control measures. According to the WHO FCTC Secretariat, such interference aims to derail consensus and weaken implementation of global tobacco control norms. In India, the Tobacco Industry Interference Index highlights instances where industry actors have sought to influence taxation and regulatory decisions.

The WHO Framework Convention on Tobacco Control (FCTC), to which India is a party, provides safeguards under Article 5.3, which mandates protection of public health policies from commercial and vested interests of the tobacco industry. It encourages transparency, limits industry participation in policymaking, and promotes accountability.

Despite marginal improvements in India’s interference index ranking, vigilance remains essential. Stronger conflict-of-interest guidelines, public disclosure norms, and civil society engagement are necessary to counter industry tactics. Protecting policy from undue influence is fundamental to achieving meaningful reductions in tobacco-related morbidity and mortality.

Tobacco control is no longer confined to health outcomes; it increasingly encompasses environmental sustainability. Trillions of cigarette butts containing plastic filters are discarded annually, leaching toxic chemicals into soil and water bodies. These filters are non-biodegradable and contribute significantly to plastic pollution. The environmental cost extends from cultivation—deforestation and pesticide use—to waste management challenges.

The 11th Conference of the Parties (COP) to the WHO FCTC addressed these concerns by discussing liability of the tobacco industry for environmental harm and measures to manage tobacco-related waste. This reflects an expanded regulatory lens that integrates environmental protection with public health.

In India, incorporating environmental considerations could involve extended producer responsibility (EPR) norms for tobacco companies, stricter waste disposal regulations, and public awareness campaigns. By framing tobacco as both a health and ecological hazard, policymakers can build broader coalitions for reform and strengthen the rationale for stricter regulation.

The tobacco control experience demonstrates the importance of comprehensive, multi-sectoral regulation combining taxation, advertising restrictions, public awareness, and international cooperation. Similar patterns of industry interference, aggressive marketing, and health externalities are observed in alcohol and ultra-processed food sectors.

For example, fiscal tools such as sin taxes on sugary drinks or alcohol can reduce harmful consumption while generating revenue for public health programmes. Transparency requirements and conflict-of-interest safeguards can prevent undue corporate influence in policy formulation. Public education campaigns can shift social norms around harmful consumption patterns.

Applying these lessons requires adapting strategies to sector-specific contexts while maintaining core principles—prioritising public health over commercial interests. As highlighted by public health experts, transferring regulatory experiences from tobacco to other industries can strengthen India’s broader approach to tackling non-communicable diseases and protecting vulnerable populations.